scispace - formally typeset
T

Thomas Costantino

Researcher at Staten Island University Hospital

Publications -  11
Citations -  722

Thomas Costantino is an academic researcher from Staten Island University Hospital. The author has contributed to research in topics: Mitral valve & Cardiomyopathy. The author has an hindex of 7, co-authored 11 publications receiving 615 citations.

Papers
More filters
Journal ArticleDOI

Neutrophil to lymphocyte ratio and cardiovascular diseases: a review

TL;DR: Neutrophil to lymphocyte ratio (NLR), which is calculated from complete blood count with differential, is an inexpensive, easy to obtain, widely available marker of inflammation, which can aid in the risk stratification of patients with various cardiovascular diseases in addition to the traditionally used markers.
Journal ArticleDOI

Current concepts in triglyceride metabolism, pathophysiology, and treatment.

TL;DR: This review will focus on triglycerides; their production, metabolism and influence on daily life, as well as the various methods for the treatment of hypertryglyceridemia and prevention of its sequelae.
Journal ArticleDOI

Reverse Takotsubo cardiomyopathy in the setting of anaphylaxis treated with high-dose intravenous epinephrine.

TL;DR: Inappropriately high doses of intravenous epinephrine can trigger stress cardiomyopathy and emergency physicians should be familiar with the diagnosis, grading, and appropriate treatments of anaphylaxis to avoid this unnecessary complication.
Journal ArticleDOI

A Prospective Study of the Effect of IV Pentamidine Therapy on Ventricular Arrhythmias and QTc Prolongation in HIV-infected Patients

TL;DR: In the absence of QTc prolongation, pentamidine therapy was not associated with a significant increase in PVCs, NSVT, or sustained VT as compared to pretherapy recordings or asCompared to therapy with TMP-SMX.
Journal ArticleDOI

Depression, disability, and quality of life after off-pump coronary artery bypass grafting: a prospective 9-month follow-up study.

TL;DR: BDI scores at baseline are good predictors of QOL at all measured intervals and should make physicians more prudent in diagnosing and observing patients undergoing OPCABG.